Tag: FDCs
DCGI asks State FDAs to restrict Tolperisone FDC for these usage...
Download DCGI's letter dated 01-09-2021
The Drugs Controller General (India) has asked the State drug controllers to restrict the...
FDC: Fixed Dose Combinations are beneficial in heart diseases: Study
A combination therapy of aspirin, statins and at least two blood pressure medications given in fixed doses can slash the risk of...
DCGI approves 3 FDCs containing Cefixime & Cefadroxil as rational
Download DCGI's latest Notices: The Drugs Controller General (India) has allowed three fixed dose combinations (FDCs) as rational with certain conditions.
CDSCO issues procedure for regulation of 19 FDCs out of 294
Download DCGI's latest Notices: The Central Drugs Standard Control Organisation (CDSCO) has issued a procedure for regulation of 19 fixed dose combinations...
Selling the FDC at higher price: Panel to examine the issue
An expert committee constituted by the National Pharmaceutical Pricing Authority (NPPA) has decided to examine the issue of selling antibacterial drug cefixime...
CDSCO extends deadline to submit details of 19 FDCs permitted before...
The Central Drugs Standard Control Organisation (CDSCO) has extended the deadline till September 25, 2021 for the stakeholders to submit details of...
Expert Committee on FDCs calls for information from stakeholders
The expert committee, constituted by the Union health ministry for examining the permission of licenses for 19 fixed dose combinations (FDCs) approved...
Parameters for evaluating FDCs should be changed: IDMA
The Sub-committee of Drugs Technical and Advisory Board (DTAB) is examining the fixed-dose combinations (FDCs) which are considered irrational by Prof Kokate...
NPPA & ICMR together will check usage of Cocktail drugs
NPPA & ICMR together will check usage of Cocktail drugs
New Delhi: The Modi government plans to increase monitoring of...
Sub-committee of DTAB on FDCs to hear stakeholders from April 19
The sub-committee, constituted for examining the fixed dose combinations (FDCs) considered as irrational by Prof Kokate Committee, has invited concerned stakeholders for...
Overmedication: NPPA to conduct Prescription audit of FDCs
The National Pharmaceuticals Pricing Authority (NPPA) has decided to carry out prescription audit to figure out the prescription patterns of fixed dose...
NPPA’s remark on approval of FDCs
The National Pharmaceutical Pricing Authority (NPPA)’s remark against approval of fixed dose combination (FDC) drugs has drawn flak from pharmaceutical industry.
DCGI extends date to submit application for Cat. ‘D’ FDCs
The Drugs Controller General of India (DCGI) has directed the manufacturers to submit application for category 'd' FDCs as per Prof. Kokate...
Latest posts
High Court restrains publishing Ads in a dispute on Chyawanprash
The Calcutta High Court has issued an interim injunction restraining Shree Baidyanath Ayurved Bhawan Pvt Ltd from issuing certain print and video...
Authors
